Inicio › Esteatosis hepática › Luisiana

Ensayos clínicos de Esteatosis hepática en Luisiana

11 estudios sobre Esteatosis hepática buscan participantes en Luisiana.

Ciudades en Luisiana

Texto oficial del estudio (inglés)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

89bio Clinical Study Site, Lafayette
89bio Clinical Study Site, Lake Charles
89bio Clinical Study Site, West Monroe

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

89bio Clinical Study Site, Covington
89bio Clinical Study Site, Houma
89bio Clinical Study Site, Lake Charles
y 2 más

ReclutandoFase 3

Edades de 18 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06318169

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Tandem Clinical Research, Plaza II, Metairie

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Tandem Clinical Research, Metairie

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Delta Research Partners of Bastrop, LLC, Bastrop
Tandem Clinical Research, Marrero
Care Access - New Iberia, New Iberia
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Akero Clinical Study Site, Bastrop
Akero Clinical Study Site, Covington
Akero Clinical Study Site, Houma
y 5 más

ReclutandoFase 3

Edades de 18 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site, Marrero

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Tandem Clinical Research, Covington
Tandem Clinical Research, Houma
Tandem Clinical Research GI, LLC, Marrero
y 4 más

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07288138

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

GSK Investigational Site, Marrero

ReclutandoFase 2

Edades de 18 a 70 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site, Bastrop
GSK Investigational Site, Marrero

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07221227

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Tandem Clinical Research, Marrero

ReclutandoFase 1/2Se aceptan voluntarios sanos

Edades de 18 a 75 · Todos los sexos · Actualizado el 16 abr 2026 · NCT05648214

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.